BRIEF-GW Pharmaceuticals Says Regains Exclusive Commercialisation Rights To Sativex In UK1 Min ReadMarch 2 (Reuters) - GW Pharmaceuticals PLC: * GW PHARMACEUTICALS REGAINS EXCLUSIVE COMMERCIALISATION RIGHTS TO SATIVEX(r) (NABIXIMOLS) IN THE UK FROM BAYER Source text for Eikon: Further company coverage:All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.(c) 2020 Reuters. All Rights Reserved.